Late to the CAR-T game, AstraZeneca quietly works on its own off-the-shelf therapies
While AstraZeneca may be a major player in the oncology space, the company has been noticeably absent as the first wave of CAR-T therapies hit the market over the past five years. | While AstraZeneca...